en

PRODUCT DETAIL

TAGRISSO 80 mg filmom obalené tablety

Code 8020B
MA number EU/1/16/1086/002
Product Form: tbl flm 30x1x80 mg (blis.Al/Al-perf.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EB Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors
L01EB04 Osimertinib
Shelf life: 36
Container: blister Al/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 02.02.2016
Validity: 24.04.2022
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 11.06.2021
eu-flag.png sk-flag.png